#nasdaqasnd

[moneyhealthfinance-blog]

Ascendis Pharma A/S (NASDAQ:ASND) price target raised to $133.00 by Canaccord Genuity

Ascendis Pharma A/S (NASDAQ:ASND) price target raised to $133.00 by Canaccord Genuity

Ascendis Pharma A/S (NASDAQ:ASND) price target raised to $ 133.00 by Canaccord Genuity

Apr 05, 2019 (Market Exclusive via COMTEX) —

Analyst Ratings For Ascendis Pharma A/S (NASDAQ:ASND)

Today, Canaccord Genuity raised its price target on Ascendis Pharma A/S (NASDAQ:ASND) to $ 133.00 per share.

There are 9 Buy Ratings, no Strong Buy Ratings, no Sell…

View On WordPress

[moneyhealthfinance-blog]

Ascendis Pharma A/S (NASDAQ:ASND) price target raised to $133.00 by Canaccord Genuity

Ascendis Pharma A/S (NASDAQ:ASND) price target raised to $133.00 by Canaccord Genuity

Ascendis Pharma A/S (NASDAQ:ASND) price target raised to $ 133.00 by Canaccord Genuity

Apr 05, 2019 (Market Exclusive via COMTEX) —

Analyst Ratings For Ascendis Pharma A/S (NASDAQ:ASND)

Today, Canaccord Genuity raised its price target on Ascendis Pharma A/S (NASDAQ:ASND) to $ 133.00 per share.

There are 9 Buy Ratings, no Strong Buy Ratings, no Sell…

View On WordPress

[moneyhealthfinance-blog]

Ascendis Pharma A/S (NASDAQ:ASND) had its Outperform rating reiterated by Wedbush with a $217.00 price target

Ascendis Pharma A/S (NASDAQ:ASND) had its Outperform rating reiterated by Wedbush with a $217.00 price target

Ascendis Pharma A/S (NASDAQ:ASND) had its Outperform rating reiterated by Wedbush with a $ 217.00 price target

Mar 07, 2019 (Market Exclusive via COMTEX) —

Analyst Ratings For Ascendis Pharma A/S (NASDAQ:ASND)

Today, Wedbush reiterated its Outperform rating on Ascendis Pharma A/S (NASDAQ:ASND) with a price target of $ 217.00.

There are 8 Buy Ratings,…

View On WordPress